Avatar
Flight43walk

3
Nic group Han ethnic group Others Occupation Office worker Manual worker Farmer Unemployed worker Others Resident Beijing resident Others Category of TB New Previously treated Drug resistance Patients with new cases of tuberculosis Susceptibility to isoniazid/rifampicin Isoniazid resistance Rifampicin resistance Multidrug resistant Patients with previously treated tuberculosis Susceptibility to is
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
Nic group Han ethnic group Others Occupation Office worker Manual worker Farmer Unemployed worker Others Resident Beijing resident Others Category of TB New Previously treated Drug resistance Patients with new cases of tuberculosis Susceptibility to isoniazid/rifampicin Isoniazid resistance Rifampicin resistance Multidrug resistant Patients with previously treated tuberculosis Susceptibility to is
1
Ontrolc DM poor controld DM bad controle4434 (77.2) 36 (63.1)5 (11.4) 9 (15.8)Reference 1.7 (0.5?.6)5 (11.4) 12 (21.1)Reference 2.3 (0.7?.1)63 (73.2)9 (10.5)1.0 (0.3?.1)14 (16.3)1.5 (0.5?.6)49 7033 (67.3) 48 (68.6) 52 (76.5)7 (14.3) 11 (15.7) 5 (7.3)Reference 1.1 (0.4?.1) 0.5 (0.1?.6)9 (18.4) 11 (15.7) 11 (16.2)Reference 0.8 (0.3?.3) 0.8 (0.3?.1)DM: diabetes mellitus; TB: tuberculosis. a Single-dr
1
Ontrolc DM poor controld DM bad controle4434 (77.2) 36 (63.1)5 (11.4) 9 (15.8)Reference 1.7 (0.5?.6)5 (11.4) 12 (21.1)Reference 2.3 (0.7?.1)63 (73.2)9 (10.5)1.0 (0.3?.1)14 (16.3)1.5 (0.5?.6)49 7033 (67.3) 48 (68.6) 52 (76.5)7 (14.3) 11 (15.7) 5 (7.3)Reference 1.1 (0.4?.1) 0.5 (0.1?.6)9 (18.4) 11 (15.7) 11 (16.2)Reference 0.8 (0.3?.3) 0.8 (0.3?.1)DM: diabetes mellitus; TB: tuberculosis. a Single-dr
1
Nic group Han ethnic group Others Occupation Office worker Manual worker Farmer Unemployed worker Others Resident Beijing resident Others Category of TB New Previously treated Drug resistance Patients with new cases of tuberculosis Susceptibility to isoniazid/rifampicin Isoniazid resistance Rifampicin resistance Multidrug resistant Patients with previously treated tuberculosis Susceptibility to is